Market statusData NSENot investment advice
NGL FINE CHEM

NGL FINE CHEM Latest Share Price (NGLFINE)

NSE: NGLFINEBSE 524774HealthcarePharmaceuticalswww.nglfinechem.com
TechnicalsTV Chart
2,907.50
33.30−1.13%
Overall Score56/100
Day range2,891
₹2,907.50
2,982
52-week1,271
₹2,907.50
3,602
Above low+128.8%
Below high19.3%
Range position70%
Open2,940.00
Prev Close2,940.80
Bid2,907.35100
Ask2,907.65100

TODAY IN ONE LINE

NGLFINE fell 1.1% on light volume, lagging Nifty's 0.1% move.

With a market cap of ₹1,804.32 Cr., it trades at a P/E of 30.41. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.

Volume7.1K64%vs 20D avg
Market Cap₹1,804.32 Cr.
Promoter72.49%
Face Value₹5
Fwd P/E
PEG
EV/EBITDA19.34
P/S3.96
ROA6.78%
Beta1.03
Div Payout2.24%
THE STOCK SCORE
Overall Score56/100
Updated 05 Sept

How good is this company?

Overall performance across 5 key dimensions.

Each card tappable → shows formula + inputs
FLAGS & NEWS

NGL FINE CHEM flags & news 

Key strengths, potential risks, and recent updates.

3 green flags🚩 1 red flag

Green Flags

  • Earnings GrowthEPS (TTM) grew by a solid 1539.8% YoY
  • High Promoter HoldingPromoters hold 72.5% skin-in-the-game
  • Zero Pledge RiskNo recent active promoter pledging found

Red Flags

Latest NGL FINE CHEM News

THE CHANGELOG

What changed recently?

Recent events, corporate actions, and announcements.

No recent changes found for this period.
🔒Prime: full history + alerts on this stock
Valuation

NGL FINE CHEM valuation: P/E, P/B and sector benchmarks.

Twelve years of multiples investors have paid for NGL FINE CHEM, framed against the sector median so the premium or discount is obvious at a glance.

NGL FINE CHEM trades at a P/E of 30.41× and P/B of 5.28×.

Key MetricsMarket + reported · 04 Sept 2026Consolidated

Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.

Valuation

Valuation

Market Cap
₹1,804.32 Cr.
P/E Ratio
30.41
P/B Ratio
5.28
EPS
₹29.78
Profitability

Profitability

ROE
13.01%
ROCE
10.54%
Net Margin
9.59%
Op Margin
12.08%
Growth

Growth

EPS YoY
1,539.8%
Revenue YoY
57.2%
Qtr Sales
1.79%
Qtr Profit
11.83%
Financial Health

Financial Health

Debt / Equity
0.34
Book Value
₹532.9
Div Yield
0.07%
Promoter Holding
72.49%
Technicals

NGL FINE CHEM technical analysis: indicators, pivots and CPR.

Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for NGL FINE CHEM — derived from the latest tape, not yesterday's close.

NGL FINE CHEM last traded at ₹2,907.5 with an intraday range of ₹2,890.5–₹2,981.9 — latest indicator, pivot and CPR signals below.

Last updated: 6 September 2026, 4:08 pm IST

Pivot points

Standard pivot — most widely referenced.

Pivot levels · Classic

Last: ₹2907.50
LevelPrice (₹)Distance% Δ
R43145.57+238.07+8.19%
R33054.17+146.67+5.04%
R23018.03+110.53+3.80%
R12962.77+55.27+1.90%
PIVOT2926.6319.130.66%
CURRENT2907.50
S12871.37-36.13-1.24%
S22835.23-72.27-2.49%
S32779.97-127.53-4.39%
S42688.57-218.93-7.53%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: 2917.07P: 2926.63TC: 2936.20
R1
R2
R3
R4
indicator
LTP: 2907.50
PDH: 2999.80
PDL: 2676.00
● Market Sentiment

NGLFINE is trading Below CPR, indicating Bearishness

● CPR Width

CPR is Wider, suggesting unlikely for trending moves

● Opening Range

Day's range: 2916.92963.6

● Price Position

Trading Inside opening range

Financials

NGL FINE CHEM financials: P&L, balance sheet, cash flow, ratios.

Reported annual and quarterly results for NGL FINE CHEM — consolidated or standalone — with margins, YoY growth and key ratios inline.

NGL FINE CHEM reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,804.32 Cr. and reported EPS of ₹29.78.

iTap any row for a plain-English meaningChange vs a year ago — green means the move is healthy for that line, red means it isn’tDerivedCalculated by us, not reported directly
Mobile view
Latest vs previous year
MetricMar 2025Mar 2026
Revenue from Operations368
501
36.0%
Sales Growth YoY %Derived8.73%
36.03%
Other Income9
15
70.7%
Total Income377
516
36.8%
182
239
31.3%
Gross ProfitDerived186
261
40.7%
Gross Margin %Derived50.47%
52.19%
152
189
24.2%
EBITDA (Operating Profit)Derived34
73
114.6%
OPM %Derived9.20%
14.51%
15
24
62.7%
Profit Before Tax (PBT)28
63
128.6%
7
15
131.3%
Effective Tax %Derived23.78%
24.05%
Total Profit for Period21
48
127.8%
Net Profit (Owner's PAT)Derived21
48
127.8%
Net Profit Margin %Derived5.74%
9.61%
PAT Growth YoY %Derived-48.87%
127.83%
Earnings Per Share (EPS ₹)34.19
77.90
127.8%
Diluted Shares Outstanding (Cr)1
1
0.0%
Other Comprehensive Income (Net of Tax)-0
-0
0.8%
Total Expenses (incl. D&A & Interest)349
452
29.5%
Material Cost % of RevenueDerived49.53%
49.35%
Employee Cost % of RevenueDerived15.08%
13.08%
Other Cost % of RevenueDerived26.19%
24.61%
Interest Coverage (x)Derived9.18x
11.89x
Sales CAGR · 3Y
+21.7%
Sales CAGR · 5Y
+14.2%
PAT CAGR · 3Y
+32.9%
PAT CAGR · 5Y
-3.2%
all values in ₹ Cr unless marked % / x / ₹ · fiscal-period end shown · reported figures via Stockezee financials API · annual results may be audited; quarterly results may be unaudited or limited-review
Segment Analysis

NGL FINE CHEM segment analysis : revenue and profit mix.

Disclosed business segments at NGL FINE CHEM with their share of revenue and profit, switchable between consolidated and standalone reporting.

NGL FINE CHEM discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.

Segment-wise Financial Analysis

Thesis

The Bull, Bear, and Flip case for NGL FINE CHEM.

Our AI distills the core fundamental drivers supporting NGL FINE CHEM, the risks that threaten it, and the quantitative conditions that could weaken the thesis.

NGL FINE CHEM's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.

bull case

What you're getting.

  • TTM revenue growth 57.2% significantly outpaces pharmaceutical sector peers at 7-11% annually.

  • Promoter holding 72.49% demonstrates strong founder commitment and long-term strategic alignment.

  • Debt-to-equity ratio 0.0034 remains exceptionally conservative, providing substantial financial flexibility.

  • Operating margin 10.60% TTM maintains profitability despite competitive pharmaceutical landscape pressures.

  • Positive operating cash flow ₹34.73 Cr (FY2026) supports dividend payments and capex funding.

bear case

Key Risks.

  • Latest quarterly EPS grew 1,536.6% YoY, signaling extreme earnings volatility and unpredictability.

  • ROCE 10.54% substantially lags peer median ~22%, indicating weak capital deployment efficiency.

  • P/E ratio 38.32x trades at premium versus peer median ~20x, suggesting overvaluation concerns.

  • Zero institutional ownership and FII holdings 0.00% raise liquidity and market confidence issues.

  • Free cash flow ₹-29.84 Cr (FY2026) negative despite positive operating cash flow signals capex strain.

flip conditions

Flip Conditions.

  • Valuation risk. a P/E above 40 would leave less room for earnings disappointment.

  • Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.

  • Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.

  • Return-quality risk. ROE below 8% would indicate weaker capital compounding.

Shareholding

NGL FINE CHEM shareholding pattern: promoters, FII, DII and public.

Quarter-on-quarter ownership shifts in NGL FINE CHEM — who is buying, who is exiting, and which institutions hold the largest positions.

Shareholding Pattern

AnnualJun 2026

Public27.43%0.19%
Promoters72.49%0.25%
FII0.05%0.02%
DII0.02%0.02%

Ownership Distribution

Retail & Public
27.43%
Promoters
72.49%
Foreign Institutions
0.05%
Domestic Institutions
0.02%

Category Trends

Foreign Institutions Breakdown
Total Holding: 0.05%
Net Change: +0.02%
Category Total0.05%
Total Holding0.05%
Net Change+0.02%
Aggregate Data
Institution Name
Trend (Last 6)
Holding %
QoQ Change
YoY ChangePeriod

Foreign Institutions: 0.05%

Individual institutional breakdown is not disclosed by the company, but aggregate holding data is shown above.

💡 This category has 0.05% total holding without detailed institution-wise disclosure
Peers

NGL FINE CHEM peer comparison — same-sector benchmarks.

Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — NGL FINE CHEM is highlighted for quick read-across.

Quick Compare

Largest by Market Cap
SUN PHARMACEUTICAL IND L
₹4.56 Lakh Cr
Best Profit Growth
SENORES PHARMACEUTICALS L
2856.31 %
Highest Dividend Yield
SANOFI INDIA
3.96 %

Peer Comparison

Company Name
09 · Chart Patterns

NGL FINE CHEM chart patterns: breakouts, tops and bottoms.

Auto-detected classical chart patterns for NGL FINE CHEM — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.

Delivery Conviction

NGL FINE CHEM delivery volume — last 20 sessions of conviction.

Daily traded volume and delivery percentage for NGL FINE CHEM over 20 sessions — the gap between intraday flipping and genuine accumulation.

Latest session delivery in NGL FINE CHEM stood at 42.7% of traded volume, against a 20-day average of 46.0%.

Avg Delivery (20D)46%-3.3 ppt latest vs avg
Highest Delivery63.8%on 31 Aug
Avg Volume (20D)19.9 K20-day run-rate
Conviction Trend↑ Strengthening-3.3 ppt latest read
Volume & Delivery · last 20 sessions
Exchange Filings & Investor Updates

NGL FINE CHEM announcements: results, concalls, ratings, M&A.

Filings NGL FINE CHEM sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.

NGL FINE CHEM files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 66 documents below.

  1. 27 Aug 2026Shareholders meetingView PDF

    Shareholders meeting

    NGL Fine-Chem Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 25, 2026. Further, the company…

  2. 25 Aug 2026Shareholders meetingView PDF

    Shareholders meeting

    NGL Fine-Chem Limited has informed the Exchange regarding Proceedings of undefined held on August 25, 2026

  3. 20 Aug 2026CorrigendumView PDF

    Corrigendum

    NGL Fine-Chem Limited has informed the Exchange regarding Corrigendum to the 45th Annual Report for the Financial Year 2025-2026

  4. 17 Aug 2026Investor PresentationView PDF

    Investor Presentation

    NGL Fine-Chem Limited has informed the Exchange about Investor Presentation

  5. 14 Aug 2026Copy of Newspaper PublicationView PDF

    Copy of Newspaper Publication

    NGL Fine-Chem Limited has informed the Exchange about Copy of Newspaper Publication

Corporate Actions

NGL FINE CHEM dividend history, splits and bonus issues.

Every dividend, stock split and bonus issue NGL FINE CHEM has declared, sequenced by announce and record date.

NGL FINE CHEM corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.

About the Company

About NGL FINE CHEM: business, sector, key facts.

What NGL FINE CHEM does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.

NGL FINE CHEM operates in the Pharmaceuticals industry under the Healthcare sector, listed as NSE: NGLFINE, BSE: 524774.

NGLFINE
Healthcare

NGL FINE CHEM

NSE · NGLFINE·BSE · 524774·www.nglfinechem.com
company facts
Employees
SectorHealthcare
HeadquartersMumbai, India
Market Cap₹1,804.32 Cr.
Listed OnNSE
leadership12 on record
Mr. Ahaan Nachane
Vice President
Mr. Dhananjay Mungale
Additional Non-Executive Director
Mr. Jayaram Sitaram
Non-Executive Independent Director
Mr. Rahul Jayant Nachane ACA, B. Com, DBF, MMS
CEO, MD, Chief Ethics Counsellor & Executive Director
Mr. Rahul Nachane
Managing Director, Director
Mr. Rajesh Lawande
Chief Financial Officer, Whole Time Director
Mr. Rajesh Narayan Lawande
Whole Time Director & CFO
Mr. Shivam Gharat
Company Secretary & Compliance Officer
Mrs. Pallavi Pednekar
Compliance Officer, Company Secretary
Mr. Sudhir Deo
Additional Non-Executive Independent Director
Ms. Ajita Nachane
Non-Executive Director
Ms. Sarala Menon
Non-Executive Woman Independent Director
§ ∞ · Plainly Answered

Questions investors ask about NGL FINE CHEM (NGLFINE).

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.

01What is the current share price of NGL FINE CHEM (NGLFINE)?

The current share price of NGL FINE CHEM (NGLFINE) is ₹2,907.50. Today, the stock has declined by ₹33.30 (1.13%), trading in a range of ₹2,890.50 to ₹2,981.90. The stock opened at ₹2,940.00 with a trading volume of 7,107 shares.

02Is NGL FINE CHEM stock a good investment for long-term?

NGL FINE CHEM can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,804.32 Cr., P/E ratio of 30.41, ROE of 13.01%, and ROCE of 10.54%. The dividend yield stands at 0.07%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.

03What is the 52-week high and low price of NGL FINE CHEM stock?

The 52-week high price of NGL FINE CHEM (NGLFINE) is ₹3,602.00, while the 52-week low is ₹1,271.00. Currently trading at ₹2,907.50, the stock is 128.76% above its 52-week low and 19.28% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.

04Should I buy NGL FINE CHEM stock at the current price?

Whether to buy NGL FINE CHEM stock at ₹2,907.50 depends on multiple factors. The stock is currently trading with a P/E ratio of 30.41 and P/B ratio of 5.28. Today's performance shows a loss of 1.13%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.

05What is the dividend yield of NGL FINE CHEM and when is the next dividend?

NGL FINE CHEM offers a dividend yield of 0.07%, which means for every ₹100 invested at the current price of ₹2,907.50, you can expect to receive approximately ₹0.07 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.

06What are the key financial ratios and metrics of NGL FINE CHEM?

NGL FINE CHEM's key financial metrics include: P/E Ratio: 30.41, P/B Ratio: 5.28, ROE: 13.01%, ROCE: 10.54%, Dividend Yield: 0.07%, EPS: ₹29.78, Book Value: ₹532.90, and Debt-to-Equity: 0.34. The company's market cap stands at ₹1,804.32 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.

07How is NGL FINE CHEM stock performing today in the market?

NGL FINE CHEM stock opened at ₹2,940.00 and is currently trading at ₹2,907.50, showing a decline of ₹33.30 (1.13%). The intraday high is ₹2,981.90 and low is ₹2,890.50. The trading volume stands at 7,107 shares, indicating moderate market participation today.

08What is the P/E ratio of NGL FINE CHEM and what does it indicate?

NGL FINE CHEM has a Price-to-Earnings (P/E) ratio of 30.41, which means investors are willing to pay 30.41 for every ₹1 of earnings. With an EPS of ₹29.78, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.

Disclaimer

The data, ratios and commentary about NGL FINE CHEM (NGLFINE) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.